4
Changes in Ownership
BridgeBio Pharma, Inc. Filed Acc 0000899243-20-024078
Chief Business Officer sold 10,000 shares at an average $28.73 ($287,334)
- Chief Business Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
HENDERSON MICHAEL THOMAS · Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 1 in the form | +10,000 | $0.16 | $1,600 | 277,751 | D |
| 2020-09-01 | Sale : show line 2 in the form | −5,022 | $27.89 | $140,083 | 272,729 | D |
| 2020-09-01 | Sale : show line 3 in the form | −4,978 | $29.58 | $147,252 | 267,751 | D |
| Open-market sales · 10,000 sh · avg $28.73 · $287,334 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-09-01 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −10,000 | $0.16 | 2028-08-26 | 10,000 | 9,487 | D |
Loading xslF345X03/doc4.xml…